Contemporary Trends in Characteristics, Treatment, and Outcomes in Acute Ischemic Stroke: Data from The Florida Stroke Registry
Abstract Body: Introduction: The evolving landscape of acute ischemic stroke (AIS) demands knowledge of the changing demographics, treatment status and stroke outcomes. Methods: Temporal trends in characteristics, presentation, guideline recommended therapies (defect free care-DFC), in-hospital mortality, and functional outcomes of AIS patients enrolled in GWTG-S, Florida Stroke Registry (FSR) were evaluated from 2012 to 2023 using multinomial temporal model adjusting for age, sex, race, severity, pre-morbid disability, time from onset to arrival and DFC. Results: A total of 311,471 AIS patients with available mortality data were included (mean age 70.7(14.2), 48.8% female, 63.6% white, 18.8% black, 13.5% Hispanic). The median onset to arrival (OTA) was 232 min [IQR=651], median NIHSS was 4 (1,9), 59% arrived by EMS, 15.3% received reperfusion therapies (11.8% IV thrombolysis, 5.4% thrombectomy, 1.9% both), 68.4% received DFC. Temporal analysis showed a trend for diminishing age (73 to 71yrs), increased median OTA (192 to 299 min), decreased median NIHSS (4 to 3), increased receipt of reperfusion therapies (9% to 17%) and DFC (18% to 83%) through the study period (p for trend <0.001). In-hospital mortality occurred in 3.2% (median presenting NIHSS 17 (8,24)), 6.2% were discharged to hospice, discharged mRS 4-5 was 40.1%, mRS 2-3 was 22.3% and mRS 0-1 was 34.4%. Multinomial adjusted temporal analysis showed stable in-hospital mortality over time (OR=1.01, 0.99,1.01, p=0.95), but increased rates of hospice admission (OR=1.036 [1.03, 1.04], p<.0001) and discharge mRS 4-5 (OR=1.01 (1.00, 1.01) P<0.0001). Conclusion: This real-world data shows a decline in age and stroke severity, and a rise in utilization of reperfusion and guideline recommended therapies in AIS patients over time. Despite improved stroke care and a stable mortality rate, a temporal increase in significant disability at discharge is observed. This data suggests an expected rise in functional burden from AIS.
Asdaghi, Negar
( University of Miami, Miller School of Medicine
, Miami
, Florida
, United States
)
Gutierrez, Carolina
( University of Miami, Miller School of Medicine
, Miami
, Florida
, United States
)
Rundek, Tatjana
( University of Miami, Miller School of Medicine
, Miami
, Florida
, United States
)
Romano, Jose
( University of Miami, Miller School of Medicine
, Miami
, Florida
, United States
)
Ying, Hao
( University of Miami, Miller School of Medicine
, Miami
, Florida
, United States
)
Gardener, Hannah
( University of Miami, Miller School of Medicine
, Miami
, Florida
, United States
)
Jameson, Angus
( University of South Florida
, Largo
, Florida
, United States
)
Rose, David
( UNIVERSITY OF SOUTH FLORIDA
, Tampa
, Florida
, United States
)
Alkhachroum, Ayham
( University of Miami
, Miami
, Florida
, United States
)
Del Brutto, Victor
( University of Miami
, Miami
, Florida
, United States
)
Perue, Gillian Gordon
( University of Miami, Miller School of Medicine
, Miami
, Florida
, United States
)
Koch, Sebastian
( University of Miami, Miller School of Medicine
, Miami
, Florida
, United States
)
Author Disclosures:
Negar Asdaghi:DO have relevant financial relationships
;
Consultant:American Heart Association:Active (exists now)
| Carolina Gutierrez:DO NOT have relevant financial relationships
| Tatjana Rundek:DO NOT have relevant financial relationships
| Jose Romano:DO NOT have relevant financial relationships
| HAO YING:DO NOT have relevant financial relationships
| Hannah Gardener:DO NOT have relevant financial relationships
| Angus Jameson:DO NOT have relevant financial relationships
| David Rose:DO have relevant financial relationships
;
Researcher:Medtronic:Active (exists now)
; Speaker:Chiesi :Active (exists now)
; Speaker:CSL:Active (exists now)
; Speaker:Boston Scientifc :Active (exists now)
; Consultant:viz:Active (exists now)
| Ayham Alkhachroum:DO NOT have relevant financial relationships
| Victor Del Brutto:DO NOT have relevant financial relationships
| Gillian Gordon Perue:No Answer
| Sebastian Koch:DO have relevant financial relationships
;
Research Funding (PI or named investigator):NIH:Active (exists now)
; Executive Role:Cerepeutics, LLC:Active (exists now)
; Research Funding (PI or named investigator):Florida Department of Health:Active (exists now)
Xu Xiaohong, Preeti Preeti, Yu Ruoying, Shaykhalishahi Hamed, Zhang Cheng, Shen Chuanbin, Li Bei, Tang Naping, Chang Yan, Xiang Qian, Cui Yimin, Lei Xi, Ni Heyu, Zhu Guangheng, Liu Zhenze, Hu Xudong, Slavkovic Sladjana, Neves Miguel, Ma Wenjing, Xie Huifang